27 11, 2016 Adriana Romiti et al., The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anti-Cancer Drugs Diatech Pharmacogenetics2016-11-27T09:58:58+01:00 Read More
